UBS’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

UBS’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-155,200	Closed	-$857K	–	11290
2014 Q1	$857K	Buy	155,200 +95,800	+161%	+$481K	﹤0.01%	3646
2013 Q4	$263K	Buy	59,400 +41,000	+223%	+$139K	﹤0.01%	4994
2013 Q3	$55K	Buy	18,400 +16,100	+700%	+$46.2K	﹤0.01%	6758
2013 Q2	$5K	Buy	+2,300	New	+$4.65K	﹤0.01%	9339

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

UBS's CHTP Position: Q2 2014 in Review

UBS sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 70,671 shares — an estimated $390K sold.

UBS first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $514K in Q4 2013. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

UBS reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
UBS sold 70,671 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $390K.
UBS first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
UBS's CHELSEA THERAPEUTICS INT'L LTD position peaked at $514K in Q4 2013.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.